Potential Drug to Prevent COVID-19- Related Heart Damage

Date: 06 August 2021 - 21:07

News ID: ۹۳۰۹۱

LONDON (Dispatches) -- Scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. The researchers used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells.
To gain entry into our cells, SARS-CoV-2 hijacks a protein on the surface of the cells, a receptor known as ACE2. Spike proteins on the surface of SARS-CoV-2 -- which give it its characteristic ‘corona’-like appearance -- bind to ACE2. Both the spike protein and ACE2 are then cleaved, allowing genetic material from the virus to enter the host cell. The virus manipulates the host cell’s machinery to allow itself to replicate and spread.
A team of scientists at the University of Cambridge has used human embryonic stem cells to grow clusters of heart cells in the lab and shown that these cells mimic the behaviour of the cells in the body, beating as if to pump blood. Crucially, these model heart cells also contained the key components necessary for SARS-CoV-2 infection -- in particular, the ACE2 receptor.
Working in special biosafety laboratories and using a safer, modified synthetic (‘pseudotyped’) virus decorated with the SARS-CoV-2 spike protein, the team mimicked how the virus infects the heart cells. They then used this model to screen for potential drugs to block infection.